Literature DB >> 2538712

The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.

S K Joseph1, H L Rice.   

Abstract

Calcium release in response to D-myo-inositol-1,4,5-trisphosphate (IP3) was compared in two microsomal preparations derived from cerebellum and forebrain, regions of the brain that differ greatly in their density of [3H]IP3 binding sites. The proportion of accumulated calcium released by IP3 was the same in both microsomal preparations when a saturating dose of IP3 was used. However, the concentration of IP3 or a nonhydrolyzable analog required to elicit half-maximal release was lower in cerebellum than in forebrain microsomes. Because cerebellum microsomes contain approximately 15 times the binding density of forebrain microsomes, the data suggest that the Ca2+ release response is proportional to the occupancy of IP3 binding sites. This was also demonstrated by the observation that heparin, an inhibitor of IP3 binding, blocked IP3-mediated Ca2+ release from both cerebellum and forebrain microsomes. The potency of heparin was dependent on IP3 concentration and was independent of receptor density. These data support the view that the receptor present in brain membranes represents the ligand-binding domain of a Ca2+ release mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538712

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Mechanisms of action of pH-induced effects on vascular smooth muscle.

Authors:  Susan Wray; R D Smith
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

2.  Inositol 1,4,5-trisphosphate-induced Ca2+ release is regulated by cytosolic Ca2+ in intact skeletal muscle.

Authors:  J R López; A Terzic
Journal:  Pflugers Arch       Date:  1996-09       Impact factor: 3.657

3.  The properties of a subtype of the inositol 1,4,5-trisphosphate receptor resulting from alternative splicing of the mRNA in the ligand-binding domain.

Authors:  J P Lièvremont; H Lancien; M Hilly; J P Mauger
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

4.  Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum.

Authors:  R A Challiss; A L Willcocks; B Mulloy; B V Potter; S R Nahorski
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

5.  Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.

Authors:  R A Challiss; E R Chilvers; A L Willcocks; S R Nahorski
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

6.  Liver inositol, 1,4,5-trisphosphate-binding sites are the Ca2(+)-mobilizing receptors.

Authors:  D L Nunn; C W Taylor
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

7.  Effect of oxidized glutathione and temperature on inositol 1,4,5-trisphosphate binding in permeabilized hepatocytes.

Authors:  D C Renard-Rooney; S K Joseph; M B Seitz; A P Thomas
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Inositol 1,4,5-triphosphate-stimulated calcium release from permeabilized cerebellar granule cells.

Authors:  E M Whitham; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

9.  Tumor necrosis factor-alpha potentiates intraneuronal Ca2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor.

Authors:  Keigan M Park; David I Yule; William J Bowers
Journal:  J Biol Chem       Date:  2008-10-06       Impact factor: 5.157

10.  Preparation and characterization of a D-myo-inositol 1,4,5-trisphosphate-specific antibody.

Authors:  W R Shieh; C S Chen
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.